Pricing Log in Create free account
Friday 6 November 2026 Export LMAT’s income statement to Excel — free account

LeMaitre Vascular, Inc.

LMAT Healthcare Medical Instruments & Supplies

LeMaitre Vascular, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $249.6 million, up 13.5% from fiscal 2024.

Revenue
+11.3%
EPS
−14.3%
Free cash flow
−25.8%
Total debt
+0.53%

Quarter to September 2026, against a year earlier

80.73 2.76 −3.31%
Market cap
$1.9B
P/E
29.7×
Fwd P/E
28.2×
Dividend yield
1.15%
F-score
6/9
Altman Z
6.99
Beneish M
−2.61
Dividend safety
93/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

LeMaitre Vascular, Inc. (LMAT) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, LeMaitre Vascular, Inc. (LMAT) trades at a EV/EBITDA of 18.9×. Over the past ten years it has ranged from 10.3× (April 2015) to 39.9× (June 2023); the current reading is higher than 26% of that period. That is above the Medical Instruments & Supplies industry median of 14.9× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 20.8× (33.56%)
FY2024 31.3× 23.55%
FY2023 25.4× (1.50%)
FY2022 25.7× 21.06%
FY2021 21.3× (4.87%)
FY2020 22.3× (14.50%)
FY2019 26.1× 106.79%
FY2018 12.6× (42.01%)
FY2017 21.8× (1.74%)
FY2016 22.2× 18.55%

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 18.8× (15.98%)
Jun 2026 22.4× (17.45%)
Mar 2026 27.2× 30.53%
Dec 2025 20.8× (16.26%)
43 more quarters

Against its own ten years

Low 10.3× High 39.9×
Ten-year median 23.3×
Current reading's percentile 26

EV/EBITDA against peers

Company EV/EBITDA
PLSE Pulse Biosciences, Inc compare n/m
KMTS Kestra Medical Technologies, Ltd. compare n/m
XRAY DENTSPLY SIRONA Inc. compare 9.3×
STVN Stevanato Group S.p.A. compare 11.3×
LMAT LeMaitre Vascular, Inc. 18.9×
STAA STAAR Surgical Company compare 50.1×
WRBY Warby Parker Inc. compare 50.2×
AZTA Azenta, Inc. compare 50.5×
ATRC AtriCure, Inc. compare 83.7×
Medical Instruments & Supplies industry median 14.9×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on LMAT